Potential of Using Cerium Oxide Nanoparticles for Protecting Healthy Tissue During Accelerated Partial Breast Irradiation (APBI)

Overview

Journal Phys Med

Specialties Biophysics
General Medicine

Date 2016 Apr 8

PMID 27053452

Citations 13

Authors

Zi Ouyang

Madan Kumar Mainali

Neeharika Sinha

Guinevere Strack

Yucel Altundal

Yao Hao

Thomas Andrew Winningham

Erno Sajo

Jonathan Celli

Wilfred Ngwa

Affiliations

Soon will be listed here.

Abstract

The purpose of this study is to investigate the feasibility of using cerium oxide nanoparticles (CONPs) as radical scavengers during accelerated partial breast irradiation (APBI) to protect normal tissue. We hypothesize that CONPs can be slowly released from the routinely used APBI balloon applicators-via a degradable coating-and protect the normal tissue on the border of the lumpectomy cavity over the duration of APBI. To assess the feasibility of this approach, we analytically calculated the initial concentration of CONPs required to protect normal breast tissue from reactive oxygen species (ROS) and the time required for the particles to diffuse to various distances from the lumpectomy wall. Given that cerium has a high atomic number, we took into account the possible inadvertent dose enhancement that could occur due to the photoelectric interactions with radiotherapy photons. To protect against a typical MammoSite treatment fraction of 3.4Gy, 5ng·g(-1) of CONPs is required to scavenge hydroxyl radicals and hydrogen peroxide. Using 2nm sized NPs, with an initial concentration of 1mg·g(-1), we found that 2-10days of diffusion is required to obtain desired concentrations of CONPs in regions 1-2cm away from the lumpectomy wall. The resultant dose enhancement factor (DEF) is less than 1.01 under such conditions. Our results predict that CONPs can be employed for radioprotection during APBI using a new design in which balloon applicators are coated with the NPs for sustained/controlled in-situ release from within the lumpectomy cavity.

Citing Articles

Radioprotective Potency of Nanoceria.

Alvandi M, Shaghaghi Z, Farzipour S, Marzhoseyni Z Curr Radiopharm. 2023; 17(2):138-147.

PMID: 37990425 DOI: 10.2174/0118744710267281231104170435.

Hybrid Polyelectrolyte Capsules Loaded with Gadolinium-Doped Cerium Oxide Nanoparticles as a Biocompatible MRI Agent for Theranostic Applications.

Kolmanovich D, Chukavin N, Savintseva I, Mysina E, Popova N, Baranchikov A Polymers (Basel). 2023; 15(18).

PMID: 37765694 PMC: 10536467. DOI: 10.3390/polym15183840.

Nanodrugs with intrinsic radioprotective exertion: Turning the double-edged sword into a single-edged knife.

Guo J, Zhao Z, Shang Z, Tang Z, Zhu H, Zhang K Exploration (Beijing). 2023; 3(2):20220119.

PMID: 37324033 PMC: 10190950. DOI: 10.1002/EXP.20220119.

Cerium Oxide Nanoparticle Administration to Skeletal Muscle Cells under Different Gravity and Radiation Conditions.

Genchi G, DeglInnocenti A, Martinelli C, Battaglini M, De Pasquale D, Prato M ACS Appl Mater Interfaces. 2021; 13(34):40200-40213.

PMID: 34410709 PMC: 8414486. DOI: 10.1021/acsami.1c14176.

CeO Nanoparticle-Containing Polymers for Biomedical Applications: A Review.

Shcherbakov A, Reukov V, Yakimansky A, Krasnopeeva E, Ivanova O, Popov A Polymers (Basel). 2021; 13(6).

PMID: 33802821 PMC: 8002506. DOI: 10.3390/polym13060924.

References

Colon J, Hsieh N, Ferguson A, Kupelian P, Seal S, Jenkins D . Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine. 2010; 6(5):698-705. DOI: 10.1016/j.nano.2010.01.010. View

Hao Y, Altundal Y, Moreau M, Sajo E, Kumar R, Ngwa W . Potential for enhancing external beam radiotherapy for lung cancer using high-Z nanoparticles administered via inhalation. Phys Med Biol. 2015; 60(18):7035-43. PMC: 4946866. DOI: 10.1088/0031-9155/60/18/7035. View

Celardo I, De Nicola M, Mandoli C, Pedersen J, Traversa E, Ghibelli L . Ce³+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles. ACS Nano. 2011; 5(6):4537-49. DOI: 10.1021/nn200126a. View

Njeh C, Saunders M, Langton C . Accelerated Partial Breast Irradiation (APBI): A review of available techniques. Radiat Oncol. 2010; 5:90. PMC: 2958971. DOI: 10.1186/1748-717X-5-90. View

Perez J, Asati A, Nath S, Kaittanis C . Synthesis of biocompatible dextran-coated nanoceria with pH-dependent antioxidant properties. Small. 2008; 4(5):552-6. DOI: 10.1002/smll.200700824. View

Wason M, Colon J, Das S, Seal S, Turkson J, Zhao J . Sensitization of pancreatic cancer cells to radiation by cerium oxide nanoparticle-induced ROS production. Nanomedicine. 2012; 9(4):558-69. PMC: 3606274. DOI: 10.1016/j.nano.2012.10.010. View

Asati A, Santra S, Kaittanis C, Perez J . Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles. ACS Nano. 2010; 4(9):5321-31. PMC: 2947560. DOI: 10.1021/nn100816s. View

Briggs A, Corde S, Oktaria S, Brown R, Rosenfeld A, Lerch M . Cerium oxide nanoparticles: influence of the high-Z component revealed on radioresistant 9L cell survival under X-ray irradiation. Nanomedicine. 2013; 9(7):1098-105. DOI: 10.1016/j.nano.2013.02.008. View

Lee S, Song W, Cho M, Puppala H, Nguyen P, Zhu H . Antioxidant properties of cerium oxide nanocrystals as a function of nanocrystal diameter and surface coating. ACS Nano. 2013; 7(11):9693-703. DOI: 10.1021/nn4026806. View

10.

Cole A . Absorption of 20-eV to 50,000-eV electron beams in air and plastic. Radiat Res. 1969; 38(1):7-33. View

11.

Jain R, Stylianopoulos T . Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol. 2010; 7(11):653-64. PMC: 3065247. DOI: 10.1038/nrclinonc.2010.139. View

12.

Altundal Y, Cifter G, Detappe A, Sajo E, Tsiamas P, Zygmanski P . New potential for enhancing concomitant chemoradiotherapy with FDA approved concentrations of cisplatin via the photoelectric effect. Phys Med. 2014; 31(1):25-30. PMC: 4492437. DOI: 10.1016/j.ejmp.2014.11.004. View

13.

Sinha N, Cifter G, Sajo E, Kumar R, Sridhar S, Nguyen P . Brachytherapy application with in situ dose painting administered by gold nanoparticle eluters. Int J Radiat Oncol Biol Phys. 2014; 91(2):385-92. PMC: 4312715. DOI: 10.1016/j.ijrobp.2014.10.001. View

14.

Beckman K, Ames B . The free radical theory of aging matures. Physiol Rev. 1998; 78(2):547-81. DOI: 10.1152/physrev.1998.78.2.547. View

15.

Marchioli R, Schweiger C, Levantesi G, Tavazzi L, Valagussa F . Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids. 2002; 36 Suppl:S53-63. DOI: 10.1007/s11745-001-0683-y. View

16.

Ngwa W, Kumar R, Sridhar S, Korideck H, Zygmanski P, Cormack R . Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine (Lond). 2014; 9(7):1063-82. PMC: 4143893. DOI: 10.2217/nnm.14.55. View

17.

Wong C, Stylianopoulos T, Cui J, Martin J, Chauhan V, Jiang W . Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci U S A. 2011; 108(6):2426-31. PMC: 3038705. DOI: 10.1073/pnas.1018382108. View

18.

Cifter G, Chin J, Cifter F, Altundal Y, Sinha N, Sajo E . Targeted radiotherapy enhancement during electronic brachytherapy of accelerated partial breast irradiation (APBI) using controlled release of gold nanoparticles. Phys Med. 2015; 31(8):1070-1074. PMC: 4946579. DOI: 10.1016/j.ejmp.2015.07.138. View

19.

Tarnuzzer R, Colon J, Patil S, Seal S . Vacancy engineered ceria nanostructures for protection from radiation-induced cellular damage. Nano Lett. 2005; 5(12):2573-7. DOI: 10.1021/nl052024f. View

20.

DiFronzo L, Tsai P, Hwang J, Lee J, Ryoo M, Rahimian J . Breast conserving surgery and accelerated partial breast irradiation using the MammoSite system: initial clinical experience. Arch Surg. 2005; 140(8):787-94. DOI: 10.1001/archsurg.140.8.787. View